share_log

康华生物(300841.SZ)收到HilleVax支付首付款1500万美元

Kanghua Biotech (300841.SZ) received a down payment of US$15 million from HillEvax

Zhitong Finance ·  Mar 26 19:56

Kanghua Biotech (300841.SZ) announced the signing of a recombinant hexavalent norovirus vaccine with HillEvax...

Zhitong Finance App News, Kanghua Biotech (300841.SZ) announced that regarding the progress of signing a license agreement with HillEvax for the recombinant six-valent norovirus vaccine, the company received a down payment of 15 million US dollars from HillEvax on March 26, 2024, of which the net amount was 13.5 million US dollars and HillEvax withheld income tax of 1.5 million US dollars.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment